Elenco degli articoli con argomento «Ruxolitinib»
Dermatologia25 set 2026
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals
In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently control AD signs/symptoms
16 lug 2026
Survey: uso di tacrolimus e pimecrolimus nella vitiligine
Survey promossa dal Dott. Andrea Paro Vidolin e MELATASK - SIDeMaST Malattie della Pigmentazione Task Force
20 nov 2025
Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo
A retrospective analysis
23 giu 2025
Off-Label Use of Topical Ruxolitinib in Dermatology
JAK inhibitors are used to treat various inflammatory skin disease
15 gen 2025
Reply to incidence of nonmelanoma skin cancer in patients with vitiligo
Reply to ‘incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream’
03 ott 2022
FDA approves Ruxolitinib
The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)